Is Immunomedics, Inc. (IMMU) a Winner in the Biotechnology Industry? – InvestorsObserver

A rating of 80 puts Immunomedics, Inc. (IMMU) near the top of the Biotechnology industry according to InvestorsObserver. Immunomedics, Inc.'s score of 80 means it scores higher than 80% of stocks in the industry. Immunomedics, Inc. also received an overall rating of 70, putting it above 70% of all stocks. Biotechnology is ranked 13 out of the 148 industries.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 70 would rank higher than 70 percent of all stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

Immunomedics, Inc. (IMMU) stock is trading at $41.15 as of 1:12 PM on Monday, Jul 6, an increase of $3.61, or 9.62% from the previous closing price of $37.54. The stock has traded between $39.22 and $41.40 so far today. Volume today is 3,753,250 compared to average volume of 3,897,633.

To see the top 5 stocks in Biotechnology click here.

Follow this link:
Is Immunomedics, Inc. (IMMU) a Winner in the Biotechnology Industry? - InvestorsObserver